Argentum Releases Visitation Guidance for Vaccinated Senior Living Communities

Posted by Argentum on March 26, 2021

Visitation is essential to the health and well-being of senior living residents. Argentum's latest guidance, "Model Visitation Protocols For Vaccinated Senior Living Communities," provides protocols, considerations, and general practices designed specifically for visitation in the variety of spaces and circumstances in senior living communities. This guidance was compiled by clinical experts, risk managers, and other stakeholders who have in-depth knowledge of senior living. 

Download Your Copy
Read More

Topics: Vaccine, Visitation

CDC Releases Interim Public Health Recommendations for Fully Vaccinated People

Posted by Argentum on March 8, 2021

Today, the CDC has released the first set of public health recommendations for those who are fully vaccinated. This guidance will be updated and expanded as more information becomes available.

Read More

Topics: Vaccine

FDA Issues EUA for Johnson & Johnson COVID-19 Vaccine

Posted by Argentum on February 27, 2021

Today, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the single-dose Janssen COVID-19 vaccine from Johnson & Johnson. This authorization suggests that the benefits outweigh its risks for use in individuals 18 of age or older and permits the vaccine to be distributed in the U.S., making it the third vaccine available in the country.

“After a thorough analysis of the data, the FDA’s scientists and physicians have determined that the vaccine meets the FDA’s expectations for safety and effectiveness appropriate for the authorization of a vaccine for emergency use,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research.
Read More

Topics: Vaccine

CDC Launches New COVID-19 Data Tracker for Pharmacy Partnership for Long-Term Care Program

Posted by Argentum on January 22, 2021

The CDC has launched a new COVID-19 Data Tracker module that includes state-specific vaccine administration information for the federal Pharmacy Partnership for Long-Term Care program. The module includes an interactive U.S. map and data, which are updated daily.

Read More

Topics: Vaccine

A Look at Current Vaccine Trends in Distribution and Administration Across Long-Term Care

Posted by Argentum on January 13, 2021

As of yesterday, the CDC reported that just under 4.4 million doses of the COVID-19 vaccine had been distributed for use in long-term care facilities. On average, 137,000 doses of vaccine are being distributed for use by this sector each day. Previously, the CDC estimated a total of 3 million people needing vaccines within this sector and as such, they have already distributed 146% of the doses needed for skilled nursing facilities, assisted living communities, and other long-term care settings.

Read More

Topics: Vaccine

CDC Rolls Out Long-Term Care Vaccination Toolkit

Posted by Argentum on December 23, 2020

The Vaccination Toolkit for Long-Term Care Facilities is now live on CDC’s website.

Read More

Topics: Vaccine

FDA Issues EUA for Moderna COVID-19 Vaccine

Posted by Argentum on December 18, 2020

Today, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the Moderna COVID-19 vaccine. This EUA permits the vaccine to be distributed in the U.S. for individuals 18 and older.

Read More

Topics: Vaccine

FDA Advisory Panel Recommends Moderna COVID-19 Vaccine for EUA

Posted by Argentum on December 17, 2020

Today, a U.S. Food & Drug Administration (FDA) advisory panel voted (20 in favor, one abstention) to recommend the Moderna COVID-19 vaccine for Emergency Use Authorization (EUA), citing that the benefits of the vaccine outweighed its risks. It is anticipated that the FDA will issue an EUA for the Moderna vaccine tomorrow. This EUA would clear the way for nearly 6 million more vaccine doses to be shipped as early as this weekend. Learn more.

Read More

Topics: Vaccine

FDA Issues EUA for the Pfizer COVID-19 Vaccine

Posted by Argentum on December 11, 2020

Today, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for the Pfizer COVID-19 vaccine, clearing the way for distribution in the United States.

Read More

Topics: Vaccine

FDA Advisory Committee Endorses Pfizer’s COVID-19 Vaccine

Posted by Argentum on December 10, 2020

Voting today that “the benefits of the Pfizer-BioNTech COVID-19 vaccine outweigh its risks for use in individuals 16 years of age and older,” the FDA’s Vaccines and Related Biological Products Advisory Committee pushed emergency use of the vaccine over a major hurdle.

Read More

Topics: Vaccine

Subscribe to Instant Email Updates

See More COVID-19 Announcements

Read more announcements related to COVID-19 on our Coronavirus Blog and access more information on:

SEE BLOG

Stay Updated on COVID-19

Find all of our latest updates on developments related to COVID-19 on our Coronavirus Toolkit.

SEE TOOLKIT